Benapryzine
Benapryzine ( ), or benaprizine ( ), also known as benapryzine hydrochloride ( in the case of the hydrochloride salt and sold under the brand name Brizin, is an antiparkinsonian agent and anticholinergic which has been used in the…
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Benapryzine ( ), or benaprizine ( ), also known as benapryzine hydrochloride ( in the case of the hydrochloride salt and sold under the brand name Brizin, is an antiparkinsonian agent and anticholinergic which has been used in the treatment of parkinsonism. As an anticholinergic, it is specifically a muscarinic acetylcholine receptor antagonist.
Structurally, benapryzine is a benzilate, and is closely related to other antimuscarinic benzilate derivatives like benactyzine. The drug was first described in the literature by 1973.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1367636724 under CC BY-SA 4.0; modifications have been made.